These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21499808)

  • 21. [Nephrectomy for renal cell carcinoma in combination with simultaneous major surgical procedures in a primary surgical hospital].
    Luithle D; Ihle V; Thiele H
    Zentralbl Chir; 2009 Sep; 134(5):474-7. PubMed ID: 19492283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating renal cell cancer in the elderly.
    Berdjis N; Hakenberg OW; Novotny V; Froehner M; Wirth MP
    BJU Int; 2006 Apr; 97(4):703-5. PubMed ID: 16536757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma.
    Hutterer GC; Patard JJ; Colombel M; Belldegrun AS; Pfister C; Guille F; Artibani W; Montorsi F; Pantuck AJ; Karakiewicz PI
    Cancer; 2007 Dec; 110(11):2428-33. PubMed ID: 17941033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based analysis of perioperative outcomes according to clinical stage.
    Takagi T; Sugihara T; Yasunaga H; Horiguchi H; Fushimi K; Kondo T; Homma Y; Tanabe K
    Int J Urol; 2014 Aug; 21(8):770-5. PubMed ID: 24712555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sociodemographic factors associated with nephrectomy in patients with metastatic renal cell carcinoma.
    Hellenthal NJ; Chamie K; Ramirez ML; deVere White RW
    J Urol; 2009 Mar; 181(3):1013-8; discussion 1018-9. PubMed ID: 19150554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical care, morbidity, mortality and follow-up after nephrectomy for renal cancer with extension of tumor thrombus into the inferior vena cava: retrospective study since 1990s.
    Rigaud J; Hetet JF; Braud G; Battisti S; Le Normand L; Glemain P; Karam G; Bouchot O
    Eur Urol; 2006 Aug; 50(2):302-10. PubMed ID: 16759789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transperitoneal laparoscopic radical nephrectomy for patients with dialysis-dependent end-stage renal disease: an analysis and comparison of perioperative outcome.
    Bird VG; Shields JM; Aziz M; De Los Santos R; Ayyathurai R; Ciancio G
    Urology; 2010 Jun; 75(6):1335-42. PubMed ID: 20035985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study.
    Marchioni M; Bandini M; Preisser F; Tian Z; Kapoor A; Cindolo L; Primiceri G; Berardinelli F; Briganti A; Shariat SF; Schips L; Karakiewicz PI
    Eur Urol Focus; 2019 May; 5(3):488-496. PubMed ID: 29229582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
    Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S
    Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older.
    Lane BR; Abouassaly R; Gao T; Weight CJ; Hernandez AV; Larson BT; Kaouk JH; Gill IS; Campbell SC
    Cancer; 2010 Jul; 116(13):3119-26. PubMed ID: 20564627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of complications following partial and total nephrectomy for renal cancer in a population based sample.
    Joudi FN; Allareddy V; Kane CJ; Konety BR
    J Urol; 2007 May; 177(5):1709-14. PubMed ID: 17437791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.
    Johnson TV; Abbasi A; Owen-Smith A; Young A; Ogan K; Pattaras J; Nieh P; Marshall FF; Master VA
    J Urol; 2010 Feb; 183(2):480-5. PubMed ID: 20006861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hospital volume and short-term outcomes after cytoreductive nephrectomy.
    Xia L; Strother MC; Taylor BL; Chelluri RR; Pulido JE; Guzzo TJ
    J Surg Oncol; 2018 Jun; 117(7):1589-1596. PubMed ID: 29575038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time.
    Bianchi M; Becker A; Hansen J; Trinh QD; Tian Z; Abdollah F; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI; Sun M
    BJU Int; 2013 Jun; 111(8):E283-9. PubMed ID: 23714646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of cytoreductive nephrectomy on eligibility for systemic treatment and effects on survival: are surgical complications or disease related factors responsible?
    O'Malley RL; Brewer KA; Hayn MH; Kim HL; Underwood W; Pili R; Schwaab T
    Urology; 2011 Sep; 78(3):595-600. PubMed ID: 21777963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The true risk of blood transfusion after nephrectomy for renal masses: a population-based study.
    Vricella GJ; Finelli A; Alibhai SM; Ponsky LE; Abouassaly R
    BJU Int; 2013 Jun; 111(8):1294-300. PubMed ID: 23368715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
    Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
    J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of surgical volume on mortality and length of stay after nephrectomy.
    Taub DA; Miller DC; Cowan JA; Dimick JB; Montie JE; Wei JT
    Urology; 2004 May; 63(5):862-7. PubMed ID: 15134966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.